• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

    3.305 -0.135 (-3.92%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,100,064
    Open 3.530
    Bid (Size) 3.250 (300)
    Ask (Size) 3.330 (1,500)
    Prev. Close 3.440
    Today's Range 3.185 - 3.569
    52wk Range 1.080 - 3.780
    Shares Outstanding 31,355,723
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
    From Cabaletta Bio
    Via GlobeNewswire

    Performance

    YTD
    +49.5%
    +49.5%
    1 Month
    +12.4%
    +12.4%
    3 Month
    +50.9%
    +50.9%
    6 Month
    +17.2%
    +17.2%
    1 Year
    +182.5%
    +182.5%

    More News

    Read More
    News headline image
    Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
    From Cabaletta Bio
    Via GlobeNewswire
    The market is filled with gapping stocks in Thursday's session. ↗
    Via Chartmill
    Why Does Cantor Fitzgerald See Over 1,000% Potential Upside For Cabaletta Bio Stock? ↗
    Via Stocktwits
    News headline image
    Cabaletta Bio Announces 2026 Strategic Priorities
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
    From Cellares
    Via Business Wire
    News headline image
    Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy ↗
    Via Benzinga
    News headline image
    Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Which stocks are experiencing notable movement on Friday? ↗
    Via Chartmill
    News headline image
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Which stocks are moving after the closing bell on Friday? ↗
    Via Chartmill
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio to Participate in Upcoming Investor Conferences in September
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction ↗
    Via Benzinga
    News headline image
    Cabaletta Bio (CABA) Q2 Loss Widens 30% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Cabaletta Bio, Inc. - Common Stock publicly traded?
    Yes, Cabaletta Bio, Inc. - Common Stock is publicly traded.
    What exchange does Cabaletta Bio, Inc. - Common Stock trade on?
    Cabaletta Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Cabaletta Bio, Inc. - Common Stock?
    The ticker symbol for Cabaletta Bio, Inc. - Common Stock is CABA on the Nasdaq Stock Market
    What is the current price of Cabaletta Bio, Inc. - Common Stock?
    The current price of Cabaletta Bio, Inc. - Common Stock is 3.305
    When was Cabaletta Bio, Inc. - Common Stock last traded?
    The last trade of Cabaletta Bio, Inc. - Common Stock was at 04/20/26 04:00 PM ET
    What is the market capitalization of Cabaletta Bio, Inc. - Common Stock?
    The market capitalization of Cabaletta Bio, Inc. - Common Stock is 103.63M
    How many shares of Cabaletta Bio, Inc. - Common Stock are outstanding?
    Cabaletta Bio, Inc. - Common Stock has 104M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.